Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons

Authors:
  • ATA. I. Terleira-Fernandez
    A. I. Terleira-Fernandez
  • MSM. L. Suarez-Gea
    M. L. Suarez-Gea
  • EVE. Vargas-Castrillon
    E. Vargas-Castrillon

Abstract
Read the full review for this F1000Prime recommended article: Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.

This publication has 42 references indexed in Scilit: